Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hu Duan

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 24, 2013
DW09849, a selective phosphatidylinositol 3-kinase (PI3K) inhibitor, prevents PI3K signaling and preferentially inhibits proliferation of cells containing the oncogenic mutation p110α (H1047R)Jia-li Liu, Guo-rui Gao, Xi Zhang, et al.
Molecular Pain|April 24, 2019
X-ray induces mechanical and heat allodynia in mouse via TRPA1 and TRPV1 activationSu Cun-Jin, Xu Jian-Hao, Liu Xu, et al.
Acta Pharmacologica Sinica|December 8, 2020
DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivoMeng-di Dai, Yue-Liang Wang, Jun Fan, et al.
Acta Pharmacologica Sinica|May 27, 2014
Identification of DW532 as a novel anti-tumor agent targeting both kinases and tubulinTing Peng, Jian-Rui Wu, Lin-Jiang Tong, et al.
Acta Pharmacologica Sinica|January 26, 2016
DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivoMeng-yuan Li, Yong-cong Lv, Lin-jiang Tong, et al.
Nature|August 13, 2004
Self-assembly of amphiphilic dendritic dipeptides into helical poresVirgil Percec, Andrés E Dulcey, Venkatachalapathy S K Balagurusamy, et al.
Acta Pharmacologica Sinica|May 7, 2013
Mycophenolic acid derivative 118 improves outcome of skin grafts by suppressing IL-17 productionFang-yuan Kong, Wei Chen, Shi-jun He, et al.
Theranostics|November 8, 2017
Multiplexed Nucleic Acid Programmable Protein ArraysXiaobo Yu, Lusheng Song, Brianne Petritis, et al.
Acta Pharmacologica Sinica|June 4, 2024
Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomasPei-Ran Song, Zhi-Peng Wan, Ge-Ge Huang, et al.
Theranostics|June 3, 2020
Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patientsQiaoyun Tan, Dan Wang, Jianliang Yang, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Pharmacology and Experimental Therapeutics|December 24, 2013
DW09849, a selective phosphatidylinositol 3-kinase (PI3K) inhibitor, prevents PI3K signaling and preferentially inhibits proliferation of cells containing the oncogenic mutation p110α (H1047R)Jia-li Liu, Guo-rui Gao, Xi Zhang, et al.
Molecular Pain|April 24, 2019
X-ray induces mechanical and heat allodynia in mouse via TRPA1 and TRPV1 activationSu Cun-Jin, Xu Jian-Hao, Liu Xu, et al.
Acta Pharmacologica Sinica|December 8, 2020
DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivoMeng-di Dai, Yue-Liang Wang, Jun Fan, et al.
Acta Pharmacologica Sinica|May 27, 2014
Identification of DW532 as a novel anti-tumor agent targeting both kinases and tubulinTing Peng, Jian-Rui Wu, Lin-Jiang Tong, et al.
Acta Pharmacologica Sinica|January 26, 2016
DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivoMeng-yuan Li, Yong-cong Lv, Lin-jiang Tong, et al.
Nature|August 13, 2004
Self-assembly of amphiphilic dendritic dipeptides into helical poresVirgil Percec, Andrés E Dulcey, Venkatachalapathy S K Balagurusamy, et al.
Acta Pharmacologica Sinica|May 7, 2013
Mycophenolic acid derivative 118 improves outcome of skin grafts by suppressing IL-17 productionFang-yuan Kong, Wei Chen, Shi-jun He, et al.
Theranostics|November 8, 2017
Multiplexed Nucleic Acid Programmable Protein ArraysXiaobo Yu, Lusheng Song, Brianne Petritis, et al.
Acta Pharmacologica Sinica|June 4, 2024
Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomasPei-Ran Song, Zhi-Peng Wan, Ge-Ge Huang, et al.
Theranostics|June 3, 2020
Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patientsQiaoyun Tan, Dan Wang, Jianliang Yang, et al.
Pageof 5